APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibody Expression Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antibody Expression Service Market Analysis and Forecast 2026-2032

4 March 2026205 pages

Choose your research edition.

Industry ResearchAntibody Expression Service Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibody Expression Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Antibody Expression Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibody Expression Service Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibody Expression Service Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Antibody Expression Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Antibody Expression Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antibody Expression Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antibody Expression Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antibody Expression Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Antibody Expression Service include GenScript, Thermo Fisher Scientific, Creative Biolabs, ProSci, Curia, Abcam, Wuxi Biologics Co., Ltd., Agilent and Sino Biological, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Antibody Expression Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antibody Expression Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Antibody Expression Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody Expression Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antibody Expression Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Antibody Expression Service revenue, projected growth trends, production technology, application and end-user industry.

Antibody Expression Service Segment by Company

GenScript

Thermo Fisher Scientific

Creative Biolabs

ProSci

Curia

Abcam

Wuxi Biologics Co., Ltd.

Agilent

Sino Biological

Bio-Rad Laboratories

Abzena

Celonic AG

Biomatik

Hangzhou Clongene Biotech Co., Ltd.

Biointron Biological Inc.

Guangzhou Huijun Biotechnology Co., Ltd.

Antibody Expression Service Segment by Type

Monoclonal Antibody Expression

Double Antibody Expression

Polyclonal Expression

Recombinant Protein Expression

Antibody Expression Service Segment by Application

Biomedicine

Clinical Diagnosis

Immunotherapy

Others

Antibody Expression Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Expression Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibody Expression Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Expression Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Antibody Expression Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Antibody Expression Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Expression Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antibody Expression Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monoclonal Antibody Expression Major Player Table 3. Double Antibody Expression Major Player Table 4. Polyclonal Expression Major Player Table 5. Recombinant Protein Expression Major Player Table 6. Global Antibody Expression Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Biomedicine Major Player Table 8. Clinical Diagnosis Major Player Table 9. Immunotherapy Major Player Table 10. Others Major Player Table 11. Antibody Expression Service Industry Trends Table 12. Antibody Expression Service Industry Drivers Table 13. Antibody Expression Service Industry Opportunities and Challenges Table 14. Antibody Expression Service Industry Restraints Table 15. Global Antibody Expression Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Antibody Expression Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Antibody Expression Service Market Share by Region (2021-2026) Table 18. Global Antibody Expression Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Antibody Expression Service Market Share by Region (2027-2032) Table 20. Global Antibody Expression Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Antibody Expression Service Revenue Market Share by Players (2021-2026) Table 22. Global Antibody Expression Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Antibody Expression Service Key Players Headquarters & Area Served Table 24. Global Antibody Expression Service Players, Product Type & Application Table 25. Global Antibody Expression Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Antibody Expression Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Antibody Expression Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Antibody Expression Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Antibody Expression Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Antibody Expression Service Revenue Market Share by Type (2021-2026) Table 32. Global Antibody Expression Service Revenue Market Share by Type (2027-2032) Table 33. Global Antibody Expression Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Antibody Expression Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Antibody Expression Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Antibody Expression Service Revenue Market Share by Application (2021-2026) Table 37. Global Antibody Expression Service Revenue Market Share by Application (2027-2032) Table 38. GenScript Company Information Table 39. GenScript Business Overview Table 40. GenScript Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. GenScript Antibody Expression Service Product Portfolio Table 42. GenScript Recent Development Table 43. Thermo Fisher Scientific Company Information Table 44. Thermo Fisher Scientific Business Overview Table 45. Thermo Fisher Scientific Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thermo Fisher Scientific Antibody Expression Service Product Portfolio Table 47. Thermo Fisher Scientific Recent Development Table 48. Creative Biolabs Company Information Table 49. Creative Biolabs Business Overview Table 50. Creative Biolabs Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Creative Biolabs Antibody Expression Service Product Portfolio Table 52. Creative Biolabs Recent Development Table 53. ProSci Company Information Table 54. ProSci Business Overview Table 55. ProSci Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. ProSci Antibody Expression Service Product Portfolio Table 57. ProSci Recent Development Table 58. Curia Company Information Table 59. Curia Business Overview Table 60. Curia Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Curia Antibody Expression Service Product Portfolio Table 62. Curia Recent Development Table 63. Abcam Company Information Table 64. Abcam Business Overview Table 65. Abcam Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Abcam Antibody Expression Service Product Portfolio Table 67. Abcam Recent Development Table 68. Wuxi Biologics Co., Ltd. Company Information Table 69. Wuxi Biologics Co., Ltd. Business Overview Table 70. Wuxi Biologics Co., Ltd. Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Wuxi Biologics Co., Ltd. Antibody Expression Service Product Portfolio Table 72. Wuxi Biologics Co., Ltd. Recent Development Table 73. Agilent Company Information Table 74. Agilent Business Overview Table 75. Agilent Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Agilent Antibody Expression Service Product Portfolio Table 77. Agilent Recent Development Table 78. Sino Biological Company Information Table 79. Sino Biological Business Overview Table 80. Sino Biological Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Sino Biological Antibody Expression Service Product Portfolio Table 82. Sino Biological Recent Development Table 83. Bio-Rad Laboratories Company Information Table 84. Bio-Rad Laboratories Business Overview Table 85. Bio-Rad Laboratories Antibody Expression Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Bio-Rad Laboratories Antibody Expression Service Product Portfolio Table 87. Bio-Rad Laboratories Recent Development Table 88. Abzena Company Information Table 89. Abzena Business Overview Table 90. Abzena Antibody Expression Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Abzena Antibody Expression Service Product Portfolio Table 92. Abzena Recent Development Table 93. Celonic AG Company Information Table 94. Celonic AG Business Overview Table 95. Celonic AG Antibody Expression Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Celonic AG Antibody Expression Service Product Portfolio Table 97. Celonic AG Recent Development Table 98. Biomatik Company Information Table 99. Biomatik Business Overview Table 100. Biomatik Antibody Expression Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Biomatik Antibody Expression Service Product Portfolio Table 102. Biomatik Recent Development Table 103. Hangzhou Clongene Biotech Co., Ltd. Company Information Table 104. Hangzhou Clongene Biotech Co., Ltd. Business Overview Table 105. Hangzhou Clongene Biotech Co., Ltd. Antibody Expression Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Hangzhou Clongene Biotech Co., Ltd. Antibody Expression Service Product Portfolio Table 107. Hangzhou Clongene Biotech Co., Ltd. Recent Development Table 108. Biointron Biological Inc. Company Information Table 109. Biointron Biological Inc. Business Overview Table 110. Biointron Biological Inc. Antibody Expression Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Biointron Biological Inc. Antibody Expression Service Product Portfolio Table 112. Biointron Biological Inc. Recent Development Table 113. Guangzhou Huijun Biotechnology Co., Ltd. Company Information Table 114. Guangzhou Huijun Biotechnology Co., Ltd. Business Overview Table 115. Guangzhou Huijun Biotechnology Co., Ltd. Antibody Expression Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Guangzhou Huijun Biotechnology Co., Ltd. Antibody Expression Service Product Portfolio Table 117. Guangzhou Huijun Biotechnology Co., Ltd. Recent Development Table 118. North America Antibody Expression Service Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Antibody Expression Service Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Antibody Expression Service Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Antibody Expression Service Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Antibody Expression Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. North America Antibody Expression Service Revenue by Country (2021-2026) & (US$ Million) Table 124. North America Antibody Expression Service Revenue by Country (US$ Million) & (2027-2032) Table 125. Europe Antibody Expression Service Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Antibody Expression Service Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Antibody Expression Service Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Antibody Expression Service Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Antibody Expression Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Antibody Expression Service Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Antibody Expression Service Revenue by Country (US$ Million) & (2027-2032) Table 132. China Antibody Expression Service Revenue by Type (2021-2026) & (US$ Million) Table 133. China Antibody Expression Service Revenue by Type (2027-2032) & (US$ Million) Table 134. China Antibody Expression Service Revenue by Application (2021-2026) & (US$ Million) Table 135. China Antibody Expression Service Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Antibody Expression Service Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Antibody Expression Service Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Antibody Expression Service Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Antibody Expression Service Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Antibody Expression Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Antibody Expression Service Revenue by Region (US$ Million) & (2021-2026) Table 142. Asia Antibody Expression Service Revenue by Region (US$ Million) & (2027-2032) Table 143. SAMEA Antibody Expression Service Revenue by Type (2021-2026) & (US$ Million) Table 144. SAMEA Antibody Expression Service Revenue by Type (2027-2032) & (US$ Million) Table 145. SAMEA Antibody Expression Service Revenue by Application (2021-2026) & (US$ Million) Table 146. SAMEA Antibody Expression Service Revenue by Application (2027-2032) & (US$ Million) Table 147. SAMEA Antibody Expression Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. SAMEA Antibody Expression Service Revenue by Country (2021-2026) & (US$ Million) Table 149. SAMEA Antibody Expression Service Revenue by Country (US$ Million) & (2027-2032) Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Antibody Expression Service Image Figure 2. Global Antibody Expression Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibody Expression Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monoclonal Antibody Expression Image Figure 5. Double Antibody Expression Image Figure 6. Polyclonal Expression Image Figure 7. Recombinant Protein Expression Image Figure 8. Global Antibody Expression Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Antibody Expression Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Biomedicine Image Figure 11. Clinical Diagnosis Image Figure 12. Immunotherapy Image Figure 13. Others Image Figure 14. Global Antibody Expression Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Antibody Expression Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Antibody Expression Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Antibody Expression Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Antibody Expression Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Antibody Expression Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antibody Expression Service Revenue Market Share by Type (2021-2032) Figure 22. Global Antibody Expression Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Antibody Expression Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Antibody Expression Service Revenue Market Share by Application (2021-2032) Figure 25. North America Antibody Expression Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Antibody Expression Service Revenue Share by Type (2021-2032) Figure 27. North America Antibody Expression Service Revenue Share by Application (2021-2032) Figure 28. North America Antibody Expression Service Revenue Share by Country (2021-2032) Figure 29. United States Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Antibody Expression Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Antibody Expression Service Revenue Share by Type (2021-2032) Figure 34. Europe Antibody Expression Service Revenue Share by Application (2021-2032) Figure 35. Europe Antibody Expression Service Revenue Share by Country (2021-2032) Figure 36. Germany Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Antibody Expression Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Antibody Expression Service Revenue Share by Type (2021-2032) Figure 46. China Antibody Expression Service Revenue Share by Application (2021-2032) Figure 47. Asia Antibody Expression Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Antibody Expression Service Revenue Share by Type (2021-2032) Figure 49. Asia Antibody Expression Service Revenue Share by Application (2021-2032) Figure 50. Asia Antibody Expression Service Revenue Share by Region (2021-2032) Figure 51. Japan Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Antibody Expression Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Antibody Expression Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Antibody Expression Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Antibody Expression Service Revenue Share by Country (2021-2032) Figure 61. Brazil Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Antibody Expression Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibody Expression
  • Double Antibody Expression
  • Polyclonal Expression
  • Recombinant Protein Expression
Applications
  • Biomedicine
  • Clinical Diagnosis
  • Immunotherapy
  • Others
Companies covered
  • GenScript
  • Thermo Fisher Scientific
  • Creative Biolabs
  • ProSci
  • Curia
  • Abcam
  • Wuxi Biologics Co., Ltd.
  • Agilent
  • Sino Biological
  • Bio-Rad Laboratories
  • Abzena
  • Celonic AG
  • Biomatik
  • Hangzhou Clongene Biotech Co., Ltd.
  • Biointron Biological Inc.
  • Guangzhou Huijun Biotechnology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antibody Expression Service Market by Type
  3. 1.2.1 Global Antibody Expression Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal Antibody Expression
  5. 1.2.3 Double Antibody Expression
  6. 1.2.4 Polyclonal Expression
  7. 1.2.5 Recombinant Protein Expression
  8. 1.3 Antibody Expression Service Market by Application
  9. 1.3.1 Global Antibody Expression Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biomedicine
  11. 1.3.3 Clinical Diagnosis
  12. 1.3.4 Immunotherapy
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Antibody Expression Service Market Dynamics
  1. 2.1 Antibody Expression Service Industry Trends
  2. 2.2 Antibody Expression Service Industry Drivers
  3. 2.3 Antibody Expression Service Industry Opportunities and Challenges
  4. 2.4 Antibody Expression Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Antibody Expression Service Market Perspective (2021-2032)
  2. 3.2 Global Antibody Expression Service Growth Trends by Region
  3. 3.2.1 Global Antibody Expression Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antibody Expression Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Antibody Expression Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Antibody Expression Service Revenue by Players
  2. 4.1.1 Global Antibody Expression Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Antibody Expression Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Antibody Expression Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antibody Expression Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Antibody Expression Service Key Players Headquarters & Area Served
  7. 4.4 Global Antibody Expression Service Players, Product Type & Application
  8. 4.5 Global Antibody Expression Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Antibody Expression Service Market CR5 and HHI
  11. 4.6.3 2025 Antibody Expression Service Tier 1, Tier 2, and Tier 3
5 Antibody Expression Service Market Size by Type
  1. 5.1 Global Antibody Expression Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Antibody Expression Service Revenue by Type (2021-2032)
  3. 5.3 Global Antibody Expression Service Revenue Market Share by Type (2021-2032)
6 Antibody Expression Service Market Size by Application
  1. 6.1 Global Antibody Expression Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Antibody Expression Service Revenue by Application (2021-2032)
  3. 6.3 Global Antibody Expression Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GenScript
  2. 7.1.1 GenScript Company Information
  3. 7.1.2 GenScript Business Overview
  4. 7.1.3 GenScript Antibody Expression Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GenScript Antibody Expression Service Product Portfolio
  6. 7.1.5 GenScript Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific Antibody Expression Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific Antibody Expression Service Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 Creative Biolabs
  14. 7.3.1 Creative Biolabs Company Information
  15. 7.3.2 Creative Biolabs Business Overview
  16. 7.3.3 Creative Biolabs Antibody Expression Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Creative Biolabs Antibody Expression Service Product Portfolio
  18. 7.3.5 Creative Biolabs Recent Developments
  19. 7.4 ProSci
  20. 7.4.1 ProSci Company Information
  21. 7.4.2 ProSci Business Overview
  22. 7.4.3 ProSci Antibody Expression Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ProSci Antibody Expression Service Product Portfolio
  24. 7.4.5 ProSci Recent Developments
  25. 7.5 Curia
  26. 7.5.1 Curia Company Information
  27. 7.5.2 Curia Business Overview
  28. 7.5.3 Curia Antibody Expression Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Curia Antibody Expression Service Product Portfolio
  30. 7.5.5 Curia Recent Developments
  31. 7.6 Abcam
  32. 7.6.1 Abcam Company Information
  33. 7.6.2 Abcam Business Overview
  34. 7.6.3 Abcam Antibody Expression Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Abcam Antibody Expression Service Product Portfolio
  36. 7.6.5 Abcam Recent Developments
  37. 7.7 Wuxi Biologics Co., Ltd.
  38. 7.7.1 Wuxi Biologics Co., Ltd. Company Information
  39. 7.7.2 Wuxi Biologics Co., Ltd. Business Overview
  40. 7.7.3 Wuxi Biologics Co., Ltd. Antibody Expression Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Wuxi Biologics Co., Ltd. Antibody Expression Service Product Portfolio
  42. 7.7.5 Wuxi Biologics Co., Ltd. Recent Developments
  43. 7.8 Agilent
  44. 7.8.1 Agilent Company Information
  45. 7.8.2 Agilent Business Overview
  46. 7.8.3 Agilent Antibody Expression Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Agilent Antibody Expression Service Product Portfolio
  48. 7.8.5 Agilent Recent Developments
  49. 7.9 Sino Biological
  50. 7.9.1 Sino Biological Company Information
  51. 7.9.2 Sino Biological Business Overview
  52. 7.9.3 Sino Biological Antibody Expression Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sino Biological Antibody Expression Service Product Portfolio
  54. 7.9.5 Sino Biological Recent Developments
  55. 7.10 Bio-Rad Laboratories
  56. 7.10.1 Bio-Rad Laboratories Company Information
  57. 7.10.2 Bio-Rad Laboratories Business Overview
  58. 7.10.3 Bio-Rad Laboratories Antibody Expression Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bio-Rad Laboratories Antibody Expression Service Product Portfolio
  60. 7.10.5 Bio-Rad Laboratories Recent Developments
  61. 7.11 Abzena
  62. 7.11.1 Abzena Company Information
  63. 7.11.2 Abzena Business Overview
  64. 7.11.3 Abzena Antibody Expression Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Abzena Antibody Expression Service Product Portfolio
  66. 7.11.5 Abzena Recent Developments
  67. 7.12 Celonic AG
  68. 7.12.1 Celonic AG Company Information
  69. 7.12.2 Celonic AG Business Overview
  70. 7.12.3 Celonic AG Antibody Expression Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Celonic AG Antibody Expression Service Product Portfolio
  72. 7.12.5 Celonic AG Recent Developments
  73. 7.13 Biomatik
  74. 7.13.1 Biomatik Company Information
  75. 7.13.2 Biomatik Business Overview
  76. 7.13.3 Biomatik Antibody Expression Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Biomatik Antibody Expression Service Product Portfolio
  78. 7.13.5 Biomatik Recent Developments
  79. 7.14 Hangzhou Clongene Biotech Co., Ltd.
  80. 7.14.1 Hangzhou Clongene Biotech Co., Ltd. Company Information
  81. 7.14.2 Hangzhou Clongene Biotech Co., Ltd. Business Overview
  82. 7.14.3 Hangzhou Clongene Biotech Co., Ltd. Antibody Expression Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Hangzhou Clongene Biotech Co., Ltd. Antibody Expression Service Product Portfolio
  84. 7.14.5 Hangzhou Clongene Biotech Co., Ltd. Recent Developments
  85. 7.15 Biointron Biological Inc.
  86. 7.15.1 Biointron Biological Inc. Company Information
  87. 7.15.2 Biointron Biological Inc. Business Overview
  88. 7.15.3 Biointron Biological Inc. Antibody Expression Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Biointron Biological Inc. Antibody Expression Service Product Portfolio
  90. 7.15.5 Biointron Biological Inc. Recent Developments
  91. 7.16 Guangzhou Huijun Biotechnology Co., Ltd.
  92. 7.16.1 Guangzhou Huijun Biotechnology Co., Ltd. Company Information
  93. 7.16.2 Guangzhou Huijun Biotechnology Co., Ltd. Business Overview
  94. 7.16.3 Guangzhou Huijun Biotechnology Co., Ltd. Antibody Expression Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Guangzhou Huijun Biotechnology Co., Ltd. Antibody Expression Service Product Portfolio
  96. 7.16.5 Guangzhou Huijun Biotechnology Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Antibody Expression Service Revenue (2021-2032)
  2. 8.2 North America Antibody Expression Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Antibody Expression Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Antibody Expression Service Revenue by Type (2027-2032)
  5. 8.3 North America Antibody Expression Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Antibody Expression Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Antibody Expression Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Antibody Expression Service Revenue by Application (2027-2032)
  9. 8.5 North America Antibody Expression Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Antibody Expression Service Revenue by Country
  11. 8.6.1 North America Antibody Expression Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Antibody Expression Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Antibody Expression Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Antibody Expression Service Revenue (2021-2032)
  2. 9.2 Europe Antibody Expression Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Antibody Expression Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Antibody Expression Service Revenue by Type (2027-2032)
  5. 9.3 Europe Antibody Expression Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Antibody Expression Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Antibody Expression Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Antibody Expression Service Revenue by Application (2027-2032)
  9. 9.5 Europe Antibody Expression Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Antibody Expression Service Revenue by Country
  11. 9.6.1 Europe Antibody Expression Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Antibody Expression Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Antibody Expression Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Antibody Expression Service Revenue (2021-2032)
  2. 10.2 China Antibody Expression Service Revenue by Type (2021-2032)
  3. 10.2.1 China Antibody Expression Service Revenue by Type (2021-2026)
  4. 10.2.2 China Antibody Expression Service Revenue by Type (2027-2032)
  5. 10.3 China Antibody Expression Service Revenue Share by Type (2021-2032)
  6. 10.4 China Antibody Expression Service Revenue by Application (2021-2032)
  7. 10.4.1 China Antibody Expression Service Revenue by Application (2021-2026)
  8. 10.4.2 China Antibody Expression Service Revenue by Application (2027-2032)
  9. 10.5 China Antibody Expression Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antibody Expression Service Revenue (2021-2032)
  2. 11.2 Asia Antibody Expression Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Antibody Expression Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Antibody Expression Service Revenue by Type (2027-2032)
  5. 11.3 Asia Antibody Expression Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Antibody Expression Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Antibody Expression Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Antibody Expression Service Revenue by Application (2027-2032)
  9. 11.5 Asia Antibody Expression Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Antibody Expression Service Revenue by Country
  11. 11.6.1 Asia Antibody Expression Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Antibody Expression Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Antibody Expression Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antibody Expression Service Revenue (2021-2032)
  2. 12.2 SAMEA Antibody Expression Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Antibody Expression Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Antibody Expression Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Antibody Expression Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Antibody Expression Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Antibody Expression Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Antibody Expression Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Antibody Expression Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Antibody Expression Service Revenue by Country
  11. 12.6.1 SAMEA Antibody Expression Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Antibody Expression Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Antibody Expression Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst